Synthetic immunotherapy induces HIV virus specific Th1 cytotoxic response and death of an HIV-1 infected human cell line through classic complement activation

Table 1 Conserved HIV protein regions containing multiple epitopes

Name	Consensus sequence	Location^a	Length
VPR	GDTWAGVEAIIRILQQLLFIHFRIGCQHSR	51 to 80	30
VIF	KVGSLQYLALTALITPKKIKPPLPSVKKLTEDRWNKPQKT	142 to 181	40
REV	EPVPLQLPPLERLTLDCSEDCGTSGTQ	69 to 95	27
NEF	YKGALDLSHFLKEKGGLEGLIYSQKRQDILDLWVYHTQGYFPD	81 to 123	43
M1A*	DLEALMEWLKTRPILSPLTKGILGFVFTLTVP	36 to 67	32
M1B*	LLYCLMVMYLNPGNYSMQVKLGTLCALCEKQASHS	124 to 158	35
NPA*	DLIFLARSALILRGSVAHKSC	255 to 275	21
NPB*	PGIADIEDLTLLARSMVVVRP	306 to 326	21
PB1*	LLIDGTASLSPGMMMGMFNMLSTVLGVSILNLGQ	395 to 428	34
M2*	IIGILHLILWILDRLFFKCIYRLF	32 to 55	24

^aAmino acid location for each sequence is referenced to the consensus sequence defined for that protein. The length of the polypeptide is expressed as number of aminoacids. Marked with (*) are the aminoacid sequences component of NRP-v.

ISSN: 1743-422X